Joanna Tyrekidis
Direktor/Vorstandsmitglied bei MyCellHub NV
Profil
Joanna Tyrekidis is currently the Director at MyCellHub NV, Fund Director at White Fund, and Head of Energy at Noshaq SA. Previously, she held the position of Chief Executive Officer at Eklo Asbl from 2019 to 2022.
She also served as a Non-Executive Director at Mithra Pharmaceuticals SA and Director at PDC Line Pharma SASU.
Ms. Tyrekidis completed her undergraduate and graduate degrees at Hec Liège Management School in 2003 and 2005, respectively.
Aktive Positionen von Joanna Tyrekidis
| Unternehmen | Position | Beginn |
|---|---|---|
Noshaq SA
 Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | Private Equity Investor | 01.11.2015 |
MyCellHub NV
 MyCellHub NV Packaged SoftwareTechnology Services MyCellHub NV offers Software as Service modules. Its services include data capturing, management and analytics. The company was founded by Toon Lambrechts, Thomas Pinna and Sébastien de Bournonville on June 9, 2019 and is headquartered in Haasrode, Belgium. | Direktor/Vorstandsmitglied | - |
| White Fund | Private Equity Investor | 01.11.2019 |
Ehemalige bekannte Positionen von Joanna Tyrekidis
| Unternehmen | Position | Ende |
|---|---|---|
Eklo Asbl
 Eklo Asbl Miscellaneous Commercial ServicesCommercial Services Eklo Asbl operates as an innovative platform. The private company is based in Liege, Belgium. The Belgian company was founded by Marc Foidart. | Vorstandsvorsitzender | 01.06.2022 |
| MITHRA PHARMACEUTICALS S.A. | Direktor/Vorstandsmitglied | - |
PDC Line Pharma SASU
 PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | Direktor/Vorstandsmitglied | - |
Ausbildung von Joanna Tyrekidis
| Hec Liège Management School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MITHRA PHARMACEUTICALS S.A. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Noshaq SA
Noshaq SA Investment ManagersFinance Noshaq SA is an independent private equity/venture capital firm founded in 1985. Noshaq SA is headquartered in Liege. | Finance |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology PDC Line Pharma SASU develops an active immuno-therapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC line) loaded with cancer antigens. It offers PDC line which displays antigen presenting cell abilities allowing the priming of antitumor na?ve CD8+ cells in vitro and in vivo (humanized mouse model). The company was founded by Laurent Levy and Joel Plumas in April 2014 and is headquartered in Grenoble, France. | Health Technology |
MyCellHub NV
MyCellHub NV Packaged SoftwareTechnology Services MyCellHub NV offers Software as Service modules. Its services include data capturing, management and analytics. The company was founded by Toon Lambrechts, Thomas Pinna and Sébastien de Bournonville on June 9, 2019 and is headquartered in Haasrode, Belgium. | Technology Services |
Eklo Asbl
Eklo Asbl Miscellaneous Commercial ServicesCommercial Services Eklo Asbl operates as an innovative platform. The private company is based in Liege, Belgium. The Belgian company was founded by Marc Foidart. | Commercial Services |
| White Fund | Finance |
